Thrombin-induced ischemic tolerance is prevented by inhibiting c-jun N-terminal kinase

Brain Research

Volumn 1148, Issue 1, 2007, Pages 217-225

  Granziera, Cristina ^a   Thevenet, Jonathan ^a   Price, Melanie ^a   Wiegler, Karine ^a   Magistretti, Pierre J ^a   Badaut, Jérôme ^a   Hirt, Lorenz ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

c jun N terminal kinase; Hippocampal slice culture; Ischemia; Middle cerebral artery occlusion; Thrombin; Tolerance

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GLUCOSE; OXYGEN; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; DRUG MECHANISM; ENZYME SUBSTRATE; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TISSUE CULTURE; TISSUE SLICE;

ANIMALS; ANTHRACENES; BRAIN; BRAIN ISCHEMIA; CELL DEATH; ENZYME INHIBITORS; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC PRECONDITIONING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED ICR; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; THROMBIN;

MUS;

EID: 34247139789     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.025     Document Type: Article

References (33)

1. Badaut J., Hirt L., Price M., de Castro Ribeiro M., Magistretti P.J., and Regli L. Hypoxia/hypoglycemia preconditioning prevents the loss of functional electrical activity in organotypic slice cultures. Brain Res. 1051 (2005) 117-122
2. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase1. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13681-13686
3. Bonny C., Oberson A., Negri S., Sauser C., and Schorderet D.F. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50 (2001) 77-82
4. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., Bogousslavsky J., and Bonny C. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9 (2003) 1180-1186
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Centeno C., Repici M., Chatton J.Y., Riederer B.M., Bonny C., Nicod P., Price M., Clarke P.G., Papa S., Franzoso G., and Borsello T. Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons. Cell Death Differ. 14 (2007) 240-253
7. De Castro Ribeiro M., Badaut J., Price M., Meins M., Bogousslavsky J., Monard D., and Hirt L. Thrombin in ischemic neuronal death. Exp. Neurol. 198 (2006) 199-203
8. Dihanich M., Kaser M., Reinhard E., Cunningham D., and Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6 (1991) 575-581
9. Donovan F.M., and Cunningham D.D. Signaling pathways involved in thrombin-induced cell protection. J. Biol. Chem. 273 (1998) 12746-12752
10. Donovan F.M., Pike C.J., Cotman C.W., and Cunningham D.D. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17 (1997) 5316-5326
11. Gloor S., Odink K., Guenther J., Nick H., and Monard D. A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 47 (1986) 687-693
12. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., and Moskowitz M.A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2007-2012
13. Hirt L., Badaut J., Thevenet J., Granziera C., Regli L., Maurer F., Bonny C., and Bogousslavsky J. d-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke 35 (2004) 1738-1743
14. Hua Y., Keep R.F., Hoff J.T., and Xi G. Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J. Cereb. Blood Flow Metab. 23 (2003) 1448-1454
15. Jiang Y., Wu J., Hua Y., Keep R.F., Xiang J., Hoff J.T., and Xi G. Thrombin-receptor activation and thrombin-induced brain tolerance. J. Cereb. Blood Flow Metab. 22 (2002) 404-410
16. Junge C.E., Sugawara T., Mannaioni G., Alagarsamy S., Conn P.J., Brat D.J., Chan P.H., and Traynelis S.F. The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13019-13024
17. Karabiyikoglu M., Hua Y., Keep R.F., Ennis S.R., and Xi G. Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow. J. Cereb. Blood Flow Metab. 24 (2004) 159-166
18. Lane D.A., Philippou H., and Huntington J.A. Directing thrombin. Blood 106 (2005) 2605-2612
19. Masada T., Xi G., Hua Y., and Keep R.F. The effects of thrombin preconditioning on focal cerebral ischemia in rats. Brain Res. 867 (2000) 173-179
20. McLaughlin B., Hartnett K.A., Erhardt J.A., Legos J.J., White R.F., Barone F.C., and Aizenman E. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 715-720
21. Sato M., Cordis G.A., Maulik N., and Das D.K. SAPKs regulation of ischemic preconditioning. Am. J. Physiol.: Heart Circ. Physiol. 279 (2000) H901-H907
22. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
23. Soifer S.J., Peters K.G., O'Keefe J., and Coughlin S.R. Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am. J. Pathol. 144 (1994) 60-69
24. Sommer C., Gass P., and Kiessling M. Selective c-JUN expression in CA1 neurons of the gerbil hippocampus during and after acquisition of an ischemia-tolerant state. Brain Pathol. 5 (1995) 135-144
25. Stoppini L., Buchs P.A., and Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37 (1991) 173-182
26. Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K.G., and Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2264-2269
27. Striggow F., Riek-Burchardt M., Kiesel A., Schmidt W., Henrich-Noack P., Breder J., Krug M., Reymann K.G., and Reiser G. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur. J. Neurosci. 14 (2001) 595-608
28. Sugino T., Nozaki K., and Hashimoto N. Activation of mitogen-activated protein kinases in gerbil hippocampus with ischemic tolerance induced by 3-nitropropionic acid. Neurosci. Lett. 278 (2000) 101-104
29. Waetzig V., and Herdegen T. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol. Sci. 26 (2005) 455-461
30. Xi G., Keep R.F., Hua Y., Xiang J., and Hoff J.T. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30 (1999) 1247-1255
31. Xi G., Hua Y., Keep R.F., Duong H.K., and Hoff J.T. Activation of p44/42 mitogen activated protein kinases in thrombin-induced brain tolerance. Brain Res. 895 (2001) 153-159
32. Xi G., Reiser G., and Keep R.F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?. J. Neurochem. 84 (2003) 3-9
33. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870